These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17030190)

  • 1. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
    Lee HC; Tian B; Sedivy JM; Wands JR; Kim M
    Gastroenterology; 2006 Oct; 131(4):1208-17. PubMed ID: 17030190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
    Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
    Schuierer MM; Bataille F; Weiss TS; Hellerbrand C; Bosserhoff AK
    Oncol Rep; 2006 Sep; 16(3):451-6. PubMed ID: 16865242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells.
    Ma J; Li F; Liu L; Cui D; Wu X; Jiang X; Jiang H
    Liver Int; 2009 Apr; 29(4):567-74. PubMed ID: 19323783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.
    Poma P; Labbozzetta M; Vivona N; Porcasi R; D'Alessandro N; Notarbartolo M
    OMICS; 2012 Nov; 16(11):579-88. PubMed ID: 23095110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Raf kinase inhibitor protein in human hepatoma tissues by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight methods.
    Tsao DA; Shiau YF; Tseng CS; Chang HR
    Indian J Cancer; 2016; 53(2):216-219. PubMed ID: 28071612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.
    Kim JS; Choi GH; Jung Y; Kim KM; Jang SJ; Yu ES; Lee HC
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1487-1501. PubMed ID: 29858683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
    Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y
    Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
    Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
    Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
    Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
    Lei X; Chang L; Ye W; Jiang C; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
    Wang S; Huang X; Li Y; Lao H; Zhang Y; Dong H; Xu W; Li JL; Li M
    Hepatology; 2011 Jun; 53(6):1932-42. PubMed ID: 21391225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently.
    Yan L; Gu H; Li J; Xu M; Liu T; Shen Y; Chen B; Zhang G
    Dig Dis Sci; 2013 Feb; 58(2):389-96. PubMed ID: 22899242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
    Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
    Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
    Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
    J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.